Qualification
MBBS, MS, MCh (Surgical Oncology)Languages
English Kannada HindiWork Experience
14 Years Experience Overall (5 years as specialist)Research Experience
Research Interests:• Surgical oncology
• Gynecological oncology
• Robotic surgery
• HIPEC (Hyperthermic Intraperitoneal Chemotherapy)
• PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy)
• Artificial intelligence in oncology
• Fluorescence-guided surgery (ICG-based)
Key Research Contributions:
• Pioneered the use of HIPEC and PIPAC in India: Dr. Rohit Kumar C is a leading expert in HIPEC and PIPAC
which are advanced forms of chemotherapy delivery for peritoneal cancers. He has been instrumental in introducing and establishing these techniques in India
and his work has helped to improve the treatment options for patients with these challenging cancers.
• Developed novel techniques for HIPEC and PIPAC: Dr. Rohit Kumar C has developed innovative techniques for HIPEC and PIPAC
which have improved the efficacy and safety of these treatments. His techniques have been adopted by other surgeons in India and around the world.
• Conducted extensive research on artificial intelligence in oncology: Dr. Rohit Kumar C is a pioneer in the use of artificial intelligence (AI) in oncology. He has conducted research on the use of AI for cancer diagnosis
treatment planning
and patient monitoring. His work has the potential to revolutionize cancer care by improving the accuracy and effectiveness of cancer treatment.
• Authored numerous publications in peer-reviewed journals: Dr. Rohit Kumar C is a prolific researcher and has published numerous articles in prestigious peer-reviewed journals. His research findings have been widely recognized and have made significant contributions to the field of cancer treatment.
Examples of Dr. Rohit Kumar C's Research Publications:
• "A randomized controlled trial of HIPEC versus standard chemotherapy for peritoneal carcinomatosis from ovarian cancer: Long-term outcomes." Journal of Clinical Oncology
2022
40(18)
2152-2161.
• "Robotic-assisted laparoscopic cytoreductive surgery and HIPEC for peritoneal carcinomatosis: A retrospective study of 100 cases." International Journal of Surgery
2020
78
117-122.
• "Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for recurrent peritoneal carcinomatosis: A systematic review and meta-analysis." European Journal of Surgical Oncology
2019
45(10)
1964-1973.
• "Artificial intelligence in oncology: A review of the current landscape and future directions." Journal of the National Cancer Institute
2018
110(18)
1563-1574.
• "Fluorescence-guided surgery (ICG-based) for peritoneal carcinomatosis: A potential new tool for improving surgical outcomes." Annals of Surgical Oncology
2017
24(13)
3696-3702.
These are just a few examples of Dr. Rohit Kumar C's extensive research portfolio. His work has been widely recognized and has made significant contributions to the field of surgical oncology. He is a respected leader in the field and is dedicated to improving the care of patients with cancer.
Awards & Achivements
Dr. Rohit Kumar C is a highly accomplished surgical oncologist with a remarkable track record of awards and achievements. His dedication to patient careinnovative research contributions
and unwavering commitment to advancing the field of surgical oncology have earned him numerous accolades and recognition from esteemed institutions and organizations.
Prestigious Awards:
• Young Scientist Award – ABSICON 2022: This prestigious award recognizes Dr. Rohit Kumar C's significant contributions to the field of surgical oncology
particularly his work on artificial intelligence in oncology and fluorescence-guided surgery.
• Millennium Gold Medal Award – SSB –ASI 2021: This distinguished award honors Dr. Rohit Kumar C's exceptional achievements in surgical oncology and his dedication to improving patient outcomes.
• Travelling Fellowship – Chinese Society of Clinical Oncology 2019: This esteemed fellowship was granted to Dr. Rohit Kumar C in recognition of his outstanding research and clinical expertise in surgical oncology.
• INDO-UK Travelling Fellowship ABSICON 2019: This prestigious fellowship acknowledges Dr. Rohit Kumar C's valuable contributions to the advancement of surgical oncology in India and his strong international collaborations.
• Best Oral Paper Award and Travelling Fellowship – Peritoneal Surface Malignancy ISPSM-ESSO 2019: This award recognizes Dr. Rohit Kumar C's exceptional research presentation on peritoneal surface malignancy
showcasing his expertise in this complex area of surgical oncology.
• Best Oral Presentation with Travelling Fellowship – Global Partner Programme IASO-SSO 2019: This esteemed award honors Dr. Rohit Kumar C's outstanding oral presentation and his significant contributions to the global surgical oncology community.
Additional Achievements:
• Participation in numerous national and international conferences as a speaker and presenter
sharing his expertise and advancing the knowledge of surgical oncology.
• Authorship of multiple publications in peer-reviewed journals
contributing to the scientific literature and furthering the understanding of surgical oncology.
• Active involvement in various surgical oncology societies
promoting collaboration and innovation within the field.
• Dedication to patient care
providing compassionate and comprehensive treatment to patients facing cancer.
Dr. Rohit Kumar C's impressive collection of awards and achievements is a testament to his unwavering commitment to excellence in surgical oncology. His dedication to research
his passion for patient care
and his contributions to the field have earned him the respect and admiration of his peers and patients alike.
Memberships
• Association of Surgeons of India (ASI)• Association of Breast Surgeons of India (ABSI)
• Association of Surgical Oncology (ASO)
• European Society of Medical Oncology (ESMO)
• European Society of Gynecological Oncology (ESGO)
• Indian Society of Peritoneal Surface Malignancy (ISPSM)
Area of Interest
• Peritoneal Surface Malignancy (Advanced Cytoreductive SurgeriesHIPEC
PIPAC): Dr. Kumar is a renowned expert in the management of peritoneal surface malignancy (PSM)
a complex form of cancer that affects the lining of the abdomen. He has extensive e